JOHN F MAULDIN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN F MAULDIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN F MAULDIN. JOHN F MAULDIN is a Director in GALECTIN THERAPEUTICS INC ($GALT) and a Director in AgeX Therapeutics, Inc. ($AGE).

Address: 7 WELLS AVENUE, SUITE 34 NEWTON 02459 MA

Companies in which JOHN F MAULDIN is an Insider

AgeX Therapeutics, Inc.

Trading Symbol: AGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN F MAULDIN: Director
Holdings: 0 shares
Latest Transaction: Mar 20 2019

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GALECTIN THERAPEUTICS INC

Trading Symbol: GALT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN F MAULDIN: Director
Holdings: 42,669 shares
Current Value: $54,190
Latest Transaction: Dec 19 2016
$GALT Market Capitalization: $34.39M
$GALT Previous Close: $1.27

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of JOHN F MAULDIN

Sentiment: All, AGE, GALT

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 20 2019AGEAgeX Therapeutics, ...MAULDIN JOHN FDirectorOption ExerciseS2.5050,000125,0000
Mar 13 2019AGEAgeX Therapeutics, ...MAULDIN JOHN FDirectorOption ExerciseA4.2865,000278,20065,000
Dec 19 2016GALTGALECTIN THERAPEUT ...MAULDIN JOHN FDirectorOption ExerciseA0.8931,25027,81331,250
Jul 08 2015GALTGALECTIN THERAPEUT ...MAULDIN JOHN FDirectorOption ExerciseD3.5916,71460,0030
Jul 08 2015GALTGALECTIN THERAPEUT ...MAULDIN JOHN FDirectorOption ExerciseD8.1014,815120,0020
Jul 08 2015GALTGALECTIN THERAPEUT ...MAULDIN JOHN FDirectorGrantA0.0025,483042,66917.2 K to 42.7 K (+148.28 %)
Jul 08 2015GALTGALECTIN THERAPEUT ...MAULDIN JOHN FDirectorGrantA0.0011,112017,1866.1 K to 17.2 K (+182.94 %)

View all JOHN F MAULDIN insider transactions.